Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/1999
10/07/1999WO1999050430A2 Modification of fatty acid composition in plants by expression of an aspergillus nidulans delta-9 coa desaturase
10/07/1999WO1999050428A2 Pathogen-inducible promoter
10/07/1999WO1999050427A2 Novel basal endosperm transfer cell layer (betl) specific genes
10/07/1999WO1999050426A1 Vectors for gene mutagenesis and gene discovery
10/07/1999WO1999050423A2 Isochorismate synthase and its use for the induction of resistance in plants
10/07/1999WO1999050417A1 Novel sequence class of genes, corresponding proteins and the use of the same
10/07/1999WO1999050416A1 Tnf-related death ligand
10/07/1999WO1999050406A2 Growth differentiation factor-9 regulatory sequences and uses therefor
10/07/1999WO1999050405A1 Secreted proteins and polynucleotides encoding them
10/07/1999WO1999050403A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999WO1999050400A1 Amp deaminase
10/07/1999WO1999050396A1 Nek1-related protein kinase
10/07/1999WO1999050394A1 Suppressive monocyte derived cells, process for their preparation and their uses in pharmaceutical compositions
10/07/1999WO1999050393A2 Use of stimulated peripheral blood mononuclear cells for the treatment of brain-related diseases, disorders and damage
10/07/1999WO1999050392A1 Methods and compositions for eliciting an immune response to a telomerase antigen
10/07/1999WO1999050391A1 Stimulated monocyte derived cells, their preparation and uses
10/07/1999WO1999050390A1 Methionin containing animal cell culture medium and its use
10/07/1999WO1999050302A1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
10/07/1999WO1999050301A2 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
10/07/1999WO1999050297A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999WO1999050288A2 Mammalian blood loss-induced gene, kd312
10/07/1999WO1999050278A1 Compositions and methods for the identification of lung tumor cells
10/07/1999WO1999049881A2 Application of hsp70 proteins
10/07/1999WO1999049876A2 Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
10/07/1999WO1999049734A1 Method of inhibiting immune system destruction of transplanted viable cells
10/07/1999WO1999040197A3 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
10/07/1999WO1999031251A9 Method and means for producing high titer, safe, recombinant lentivirus vectors
10/07/1999WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999WO1999029880A3 Method for producing transgenic plants with modified 5-aminolevulinic acid biosynthesis, method for identifying 5-aminolevulinic acid synthesis effectors
10/07/1999WO1999029717A3 Postweaning multisystemic wasting syndrome virus from pigs
10/07/1999WO1999015668A3 Banana proteins, dna, and dna regulatory elements associated with fruit development
10/07/1999DE19816395A1 Menschliche Nukleinsäuresequenzen aus Ovar-Normalgewebe Nucleic acid sequences from human ovarian normal tissue
10/07/1999DE19814701A1 Verwendung von stimulierten mononukleären Zellen des peripheren Blutes zur Behandlung von mit dem Gehirn assoziierten Erkrankungen, Störungen und Schädigungen Use of stimulated peripheral blood mononuclear cells for the treatment of brain-related diseases, disorders and injuries
10/07/1999CA2347067A1 Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
10/07/1999CA2333433A1 Salicylic acid pathway genes and their use for the induction of resistance in plants
10/07/1999CA2326573A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999CA2325735A1 Hsp70 protein for the treatment of tumours, cancer or infectious diseases through nk-cell activation
10/07/1999CA2325564A1 Inducible alphaviral gene expression system
10/07/1999CA2325054A1 Amp deaminase
10/07/1999CA2324969A1 Pathogen-inducible promoter
10/07/1999CA2324652A1 Nek1-related protein kinase
10/07/1999CA2324492A1 Secreted proteins and polynucleotides encoding them
10/07/1999CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999CA2324286A1 Growth differentiation factor-9 regulatory sequences and uses therefor
10/07/1999CA2323836A1 Novel sequence class of genes, corresponding proteins and the use of the same
10/07/1999CA2323833A1 Compositions and methods for the identification of lung tumor cells
10/07/1999CA2323524A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999CA2321179A1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
10/07/1999CA2320491A1 Stimulated monocyte derived cells, their preparation and uses
10/07/1999CA2290363A1 Method of inhibiting immune system destruction of transplanted viable cells
10/06/1999EP0947583A2 DNA fragments activated in expression of melanoma inhibiting protein (MIA)
10/06/1999EP0947581A1 Culture medium and use of the same
10/06/1999EP0947525A1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
10/06/1999EP0946872A1 Gastric submucosal tissue as a novel diagnosis tool
10/06/1999EP0946743A1 A method of enhancing the rate of transfection of cells
10/06/1999EP0946737A2 Herbicide resistant plants
10/06/1999EP0946730A2 Mutants of streptococcal toxin c and methods of use
10/06/1999EP0946726A2 A variant human alpha-7 acetylcholine receptor subunit, and methods of production and use thereof
10/06/1999EP0946725A2 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
10/06/1999EP0946723A1 Recombinase-activatable aav packaging cassettes for use in the production of aav vectors
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946721A1 Human growth gene and short stature gene region
10/06/1999EP0946719A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
10/06/1999EP0946718A1 Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells
10/06/1999EP0946717A1 Transgenic plants expressing assembled secretory antibodies
10/06/1999EP0946713A1 Method for in vitro preconditioning of myoblasts before transplantation
10/06/1999EP0946591A2 Cloned glucagon-like peptide-2 receptors
10/06/1999EP0946201A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
10/06/1999EP0946199A1 TGF beta 1-RESPONSIVE CELLS FROM BONE MARROW
10/06/1999EP0946138A2 Use of a potentilla erecta extract in the cosmetic and pharmaceutical field
10/06/1999EP0946127A2 Biopolymer foams for use in tissue repair and reconstruction
10/06/1999EP0946102A2 Methods for conferring insect resistance to a monocot using a peroxidase coding sequence
10/06/1999EP0726951B1 Manufacture and use of polypeptides tagged using binding molecules
10/06/1999EP0517815B1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE
10/06/1999CN1230996A Chimera gene with several herbicide resistant genes, plant cell and plant resistant to several herbicides
10/06/1999CN1230991A Hamster EF-1 'alpha' transcriptional regulatory DNA
10/06/1999CN1230989A Embryonic or stem-like cell lines produced by cross species nuclear transplantation
10/06/1999CN1230893A Assembly-deficient herpesvirus vaccine
10/06/1999CN1230591A Monoclone antibody cell strain and its monoclone antibody with hepatitis C virus resisting non-structure zone 4 antigen
10/06/1999CN1230549A Escape mutant of surface antigen of hepatitis B virus
10/05/1999US5962769 Induction of male sterility in plants by expression of high levels of avidin
10/05/1999US5962768 Kanamycin resistance
10/05/1999US5962653 Methods of obtaining antiviral proteins and antiviral peptides from Nostoc ellipsosporum
10/05/1999US5962652 Antibodies to protein, FAF1
10/05/1999US5962648 Human procollagen or collagen produced in this manner can be made of a single collagen type uncontaminated by other human or non-human collagens.
10/05/1999US5962410 Fungicides, antiprotozoa agent
10/05/1999US5962325 Three-dimensional stromal tissue cultures
10/05/1999US5962324 Selecting optic cells for culture, introducing cells and attachment means into rotating cylindrical culture vessel, culturing during horizontal rotation modulated to create low shear conditions forming extracellular, optic tissue matrices
10/05/1999US5962323 Introducing cells into vessel containing medium comprising an acidic fibroblast growth factor and culturing to increase number of cells; for bone marrow transplantation and gene therapy of hematopoeitic disorders
10/05/1999US5962321 Leukemia inhibitory factor from mammalian species and use thereof to enhance implantation and development of embryos
10/05/1999US5962320 Engineered antigen presenting cells and methods for their use
10/05/1999US5962318 Cytotoxic T lymphocyte-mediated immunotherapy
10/05/1999US5962317 Circulating simulated body fluid in loop connected with central reservoir and bioreactor including cells, allowing fluid to wash drug from port causing mixing, monitoring effect of drug; mixing without mechanical stirring
10/05/1999US5962316 Cell-cycle regulatory proteins, and uses related thereto
10/05/1999US5962313 Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
10/05/1999US5962312 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
10/05/1999US5962303 The invention relates to polynucleotides and polypeptides of bacterial ?topoisomerase iii.?
10/05/1999US5962300 Polynucleotide which encodes a polypeptide tumor suppressor; for diagnosis, prevention, and treatment of cancer, eczema, psoriasis, psoriasis, scleroderma, dermatitis, skin atrophy, and other skin disorders; anticarcinogenic agents
10/05/1999US5962298 Influenza vaccine
10/05/1999US5962295 This invention relates to newly identified polynucleotides and polypeptides, and their production and uses, as well as their variants, agonists and antagonists, and their uses.
1 ... 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 ... 1827